Latest filing published 15 Apr 2025 for Kyverna Therapeutics, Inc..
Ryan Alexander Jones is a declared insider of Kyverna Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 28 May 2024 and 11 April 2025, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 15 April 2025, the filings show a share grant in Kyverna Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations